China Medical Technologies HIFU System to Expand Overseas Market

From China Medical Technologies (Nasdaq: CMED) learned that the company's High Intensity Focused Ultrasound (HIFU) tumor therapy system has been the Korea Food and Drug Administration approval. China Medical Technologies will be formally put to the Korean market this system, and this will be the first time in China HIFU system outside the market.

China Medical Technologies CEO Wu Xiaodong said, following the July 2007 HIFU system of the FDA's conditional approval to begin human clinical trials into the stage, this is granted in South Korea made another HIFU system milestones like progress.

It is learned that at present in South Korea have more than 1,000 general hospitals. China Medical Technologies the exclusive distributor in South Korea will be the first to aim at sales of large general hospitals to promote HIFU tumor therapy system. In addition, the company will also regularly review companies and dealers in the Korean market sales strategies, and objectives focus on South Korea's long-term market.

Source: 中国行业研究网 Oct. 18, 2007